CLOFARABINE
Generic: CLOFARABINE
Eugia US LLCManufacturer
INTRAVENOUSRoute
CLOFARABINEActive Substance
2022-10-03Original Approval
CLOFARABINE is FDA application ANDA212457, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FEBRILE NEUTROPENIA
270 reports
2
OFF LABEL USE
239 reports
3
PYREXIA
207 reports
4
DRUG INEFFECTIVE
196 reports
5
SEPSIS
160 reports
6
MUCOSAL INFLAMMATION
125 reports
7
NEUTROPENIA
121 reports
8
NAUSEA
111 reports
9
DEATH
104 reports
10
VOMITING
101 reports